Diagnosis

Hypercalcemia

Serum Ca > 15 mg/dL.[3rt]

  • Corrected calcium:

    • 0.8 (Normal Albumin - Observed Albumin) + Observed Calcium

    • Corrected calcium (mmol/L) = measured calcium + ([40 - albumin (g/L)] × 0.02)

    • Measured calcium + 0.8 x (4.0 - albumin)

Etiology

Cause

Pathophysiology [cdh]

  1. Calcium plays an integral role in neural transmission, enzyme activity, myocardial function, coagulation, intracellular signaling, and hormonal secretion.

  2. Most of the calcium is found in the bones as calcium phosphate, whereas a small percentage is found in cells and extracellular fluids.

  3. Approximately 50% of total calcium is protein bound, and the total calcium level will vary with protein-binding capacity (albumin).

  4. Acidosis (increased hydrogen ions) occupy binding sites on albumin, leading to increased free calcium levels. Thus, calcium levels should be adjusted for serum pH.

  5. The main regulators of calcium homeostasis: [cdh]

    • Parathyroid hormone: Binding to osteoclasts --> increases bone resorption --> increase serum calcium

    • Vitamin D: Increases intestinal absorption of calcium

    • Calcitonin: Increasing calcium deposition in bones + inhibiting renal and intestinal absorption of calcium + increasing urinary calcium excretion --> lowers serum calcium levels

Complications [cdh]

Epidemiology

Incidence per 100.000 [asw][qsc][3rt][ug6][bpg]

Epidemiology chart for Incidence

Prevalence per 100.000 [asw][qsc][3rt][ug6][bpg]

Epidemiology chart for Prevalence

Symptoms & findings

Symptoms

Anorexia, Anxiety, Arrhythmia, Arthralgia, Coma, Confusion, Constipation, Depression, Fatigue, Headache, Hematuria, Hypertension, Hyporeflexia, Muscle weakness, Nausea, Nocturia, Polydipsia, Polyuria, Stupor, Tachycardia, Thirst, Vomiting, Weakness, Weight loss

Clinical findings

Elevated PTH, Lytic bone lesion, Osteoporosis, Pathologic fracture, Shortened QT interval, U wave

Anamneses

Acute pancreatitis

Localized findings

Pain
Radiates
GeneralBone (skeleton)JointsCaputAbdomenArmBackLower body
Onset
Gradual (days)
Pattern
Constant
Severity
Mild (1-3)Moderate (4-7)

Approach

Treatment

  1. Goal of treatment: [cdh]

    • Increased elimination from the extracellular fluid

    • Reduced gastrointestinal absorption

    • Decreased bone resorption

  2. Treat the underlying cause:

    • Parathyroidectomy: if primary hyperparathyroidism

    • Discontinue thiazide

    • Inhibit osteoclasts

  3. Adequate hydration with increased urinary excretion of calcium [nbi]:

    • Hydration: Isotonic NaCl (0.9% saline until adequate urine output)

    • Loop diuretics

  4. Electrolyte replacement: [cdh]

    • Hypokalemia

    • Hypomagnesemia

    • Hypophosphatemia

  5. Calcitonin 4 units/kg every 12 hours to acutely lower calcium levels

  6. Biophosphonates: treating hypercalcemia of malignancy, takes 3 days to lower calcium

  7. Denosumab: treating hypercalcemia of malignancy, antibody inhibits osteoclasts

  8. Corticoids: if lymphoma or granulomatous disease, Prednisone 20-40 mg daily

  9. Mithramycin: inhibits osteoclast RNA synthesis

  10. Cinacalcet (suppression of PTH): treating secondary hyperparathyroidism due to renal failure

  11. Peritoneal dialysis or hemodialysis is rarely needed

Differential diagnoses

Brain tumor, Breast cancer, Cervical cancer, Drug side effects, Hyperparathyroidism, Hypovolemia, Leukemia, Lung cancer, Lymphoma, Multiple myeloma, Ovarian cancer, Renal cancer, Sarcoidosis, Urolithiasis


References

[1] Dent DM, Miller JL, Klaff L, Barron J. The incidence and causes of hypercalcaemia. Postgrad Med J. 1987 Sep;63(743):745-50.

[2] Yeh MW, Ituarte PH, Zhou HC, Nishimoto S, Liu IL, Harari A, Haigh PI, Adams AL. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013 Mar;98(3):1122-9.

[3] Rizk Y, Saad N, Arnaout W, Chalah MA, Farah S. Primary Hyperparathyroidism in Older Adults: A Narrative Review of the Most Recent Literature on Epidemiology, Diagnosis and Management. J Clin Med. 2023 Sep 30;12(19):6321.

[4] Sadiq NM, Anastasopoulou C, Patel G, et al. Hypercalcemia. [Updated 2024 May 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430714/

[5] Lecoq AL, Livrozet M, Blanchard A, Kamenický P. Drug-Related Hypercalcemia. Endocrinol Metab Clin North Am. 2021 Dec;50(4):743-752.

[6] Jick S, Li L, Gastanaga VM, Liede A. Prevalence of hypercalcemia of malignancy among cancer patients in the UK: analysis of the Clinical Practice Research Datalink database. Cancer Epidemiol. 2015 Dec;39(6):901-7.

[7] Smaranda Diaconescu, Nicoleta Gimiga, Claudia Olaru, Marin Burlea. Hypercalcemia in Children. Romanian Journal of Oral Rehabilitation Vol. 6, No. 3, July September 2014.

[8] Wermers RA, Kearns AE, Jenkins GD, Melton LJ 3rd. Incidence and clinical spectrum of thiazide-associated hypercalcemia. Am J Med. 2007 Oct;120(10):911.e9-15.

[9] Griebeler ML, Kearns AE, Ryu E, Hathcock MA, Melton LJ 3rd, Wermers RA. Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010). Bone. 2015 Apr;73:1-7.

Scroll to top